U.S. Markets closed

Amag’s plan to bypass female libido drug pitfalls? Social media.

Allison DeAngelis
Amag’s plan to bypass female libido drug pitfalls? Social media.

Amag Pharmaceuticals Inc. has received regulatory approval to begin selling Vyleesi, a drug designed to address hypoactive sexual disorder, a condition in which causes low sexual desire and distress in an estimated one in 10 women.